Rational combination of <scp>SHP2</scp> and <scp>mTOR</scp> inhibition for the treatment of hepatocellular carcinomaAntonio Mulero‐Sánchez, Sara Mainardi, Christel Ramirez et al.|Molecular Oncology|2023Cited by 14
Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumorsDennis S. Metselaar, Esther Hulleman, Neal Geisemeyer et al.|Cell Reports Medicine|2024Cited by 8
DIPG-51. DIFFUSE MIDLINE GLIOMAS HIJACK MYELOID CELL POPULATIONS TO INITIATE AN ANTI-INFLAMMATORY TUMOR IMMUNE MICROENVIRONMENTDennis S. Metselaar, Esther Hulleman, Aimée du Chatinier et al.|Neuro-Oncology|2024Cited by 1